Document Detail

Factors associated with early adherence to tiotropium in chronic obstructive pulmonary disease.
MedLine Citation:
PMID:  23149384     Owner:  NLM     Status:  Publisher    
Tiotropium is an innovative intervention in chronic obstructive pulmonary disease (COPD). Early adherence to tiotropium remains inadequately explored, notably time from initiation to discontinuation (persistence). In patients with COPD, the factors associated with the risk of discontinuing the treatment with tiotropium within 12 months following initiation were identified (12-month persistence). Claim databases from the French Social Security were used. A random sample of patients (aged 50-80 years) who initiated tiotropium soon after launch was selected. Factors associated with the persistence were investigated (Log-rank test and multivariate Cox model). Of the 1147 newly treated patients (mean age 68 years, 33% women), 64% remained in the treatment of tiotropium for over a period of 12 months following initiation. More than 10% of the patients interrupted therapy after a single dispensing, most often those with mild COPD. Lower risks of discontinuing tiotropium within 12 months following initiation were observed when it was initiated by a private sector specialist (hazard ratio (HR) = 0.65, 95% confidence interval (CI) = (0.52-0.82)), by hospital-based physician (HR = 0.58, 95% CI = (0.42-0.78)), when ≥ 2 other respiratory drugs were associated (HR = 0.74, 95% CI = (0.58-0.95)) and in case of long-term disease status (HR = 0.78, 95% CI = (0.63-0.97)). Conversely, no clear effect appeared according to age or gender. In this population of patients with COPD, fewer early discontinuations of tiotropium were observed in patients having a severe condition.
Laurent Laforest; Idlir Licaj; Gilles Devouassoux; Susanne Hartwig; Serge Marvalin; Eric Van Ganse
Related Documents :
22934534 - Long-term impact of entecavir monotherapy in chronic hepatitis b patients with a partia...
2937074 - Treatment of the painful neuroma by neuroma resection and muscle implantation.
24728244 - Use of rituximab as a treatment for systemic lupus erythematosus: retrospective review.
24372674 - Effect of tamsulosin on stone expulsion in proximal ureteral calculi: an open-label ran...
18760144 - Symptoms of chest pain and dyspnea and factors associated with chest pain and dyspnea 1...
20301084 - Do statins delay the incidence of esrd in diabetic patients with moderate ckd?
Publication Detail:
Type:  JOURNAL ARTICLE     Date:  2012-11-13
Journal Detail:
Title:  Chronic respiratory disease     Volume:  -     ISSN:  1479-9731     ISO Abbreviation:  Chron Respir Dis     Publication Date:  2012 Nov 
Date Detail:
Created Date:  2012-11-14     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  101197408     Medline TA:  Chron Respir Dis     Country:  -    
Other Details:
Languages:  ENG     Pagination:  -     Citation Subset:  -    
Unite de Pharmacoepidemiologie, CHU-Lyon, d'Odontologie - UMR 5558 CNRS - Universite Claude Bernard Lyon, France.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Volitional pursed lips breathing in patients with stable chronic obstructive pulmonary disease impro...
Next Document:  OXPHOS mutations and neurodegeneration.